Alcohol could potentially interfere with the effects of BPC 157, but specific interactions havent been widely studied
Communicate needs to employers early rather than pushing through pain
Frequency of treatment is determined based on your goals and provider recommendation
PMID 3927946
In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
Drawing 12.5 units for a 2.5mg starting dose requires careful technique